Close Menu

NEW YORK (GenomeWeb) – Cell-based cancer diagnostics company Celcuity today said in a regulatory document that it intends to offer 2 million shares of its common stock at between $8 and $10 per share as part of its initial public offering.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.